Skip to main content
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
124.51
+2.10 (1.72%)
Oct 11, 2024, 4:00 PM EDT - Market closed

Sarepta Therapeutics Revenue

Sarepta Therapeutics had revenue of $362.93M in the quarter ending June 30, 2024, with 38.93% growth. This brings the company's revenue in the last twelve months to $1.50B, up 49.98% year-over-year. In the year 2023, Sarepta Therapeutics had annual revenue of $1.24B with 33.26% growth.

Revenue (ttm)
$1.50B
Revenue Growth
+49.98%
P/S Ratio
7.89
Revenue / Employee
$1,145,352
Employees
1,314
Market Cap
11.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.24B310.32M33.26%
Dec 31, 2022933.01M231.13M32.93%
Dec 31, 2021701.89M161.79M29.96%
Dec 31, 2020540.10M159.27M41.82%
Dec 31, 2019380.83M79.80M26.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG 20.80B
Solventum 8.21B
Smith & Nephew 5.64B
Catalent 4.38B
Teleflex 3.01B
Royalty Pharma 2.24B
Neurocrine Biosciences 2.12B
Medpace Holdings 2.03B
Revenue Rankings

SRPT News

More News